Myomo (MYO) Director Reports 50K Share Purchase at $1.10
Rhea-AI Filing Summary
Myomo, Inc. director Thomas F. Kirk reported open-market purchases of 50,000 shares of Myomo common stock on 08/18/2025 at an execution price of $1.10 per share (two transactions at $1.10 each). Following these purchases, Mr. Kirk beneficially owned 424,420 shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing states the purchases were open-market trades and that details can be provided to the SEC upon request.
Positive
- Director purchase disclosed: The Form 4 reports an open-market acquisition of 50,000 shares, indicating insider activity is transparently reported.
- Clear post-transaction ownership: Reporting person beneficially owns 424,420 shares following the reported transactions.
- Complete transaction details provided: Transaction date, price ($1.10), and transaction code (P) are included, and the filing is signed by an authorized attorney-in-fact.
Negative
- None.
Insights
TL;DR: Director executed a notable open-market buy of 50,000 shares at $1.10, increasing direct ownership to 424,420 shares.
The transaction is a simple, disclosed open-market purchase reported on Form 4. The purchase price and share count are explicit, and the filing confirms direct beneficial ownership after the trades. From a trading-disclosure perspective, the report is complete for non-derivative activity and includes the reporting attorney-in-fact signature. There are no earnings or capital-structure changes disclosed in this filing.
TL;DR: A company director reported purchased stock, properly disclosed on Form 4 with required signature.
The filing shows compliance with Section 16 reporting: the reporting person is identified as a director, transaction codes and share counts are provided, and the form is executed by an attorney-in-fact. The filer notes the trades were open-market and offers to provide transaction details to the SEC on request, which is standard. No derivatives, plans, or exemptions are indicated in the disclosure.